Caregility and Eko Partner to Bring Smart Stethoscope Technology to Award-Winning Enterprise Telehealth Platform

Caregility, an enterprise telehealth platform company, and Eko, the market leader in stethoscopes for telehealth, today announced an integration partnership. Caregility’s cloud platform now seamlessly integrates with Eko’s smart stethoscopes and software, enabling users of Caregility’s iConsult application to perform high-quality auscultation (heart, lung, and other body sounds) on patients during a virtual physical exam.

“Our partnership addresses a key component missing from most virtual exams – auscultation. The ability for care teams to easily and accurately assess a patient’s body sounds in real-time will have a meaningful impact on our hybrid care delivery models, including telenursing, telerounding, tele-ICU, and at-home care,” said Peter McLain, Chief Strategy Officer and SVP of Business Development at Caregility. “Eko’s unparalleled digital stethoscope sound quality and waveform visualization software will build clinician confidence, reduce workflow friction, and ultimately improve patient outcomes.”

This partnership integrates Eko Connect, Eko’s suite of telehealth APIs, with Caregility Cloud™. Caregility’s award-winning telehealth solution now has access to live-streaming stethoscope sounds with real-time phonocardiogram (PCG) and electrocardiogram (ECG)* waveform visualization within a familiar interface. The integration is compatible with Eko’s complete line of smart stethoscopes, including the CORE Digital Stethoscope Attachment, 3M™ Littmann® CORE Digital Stethoscope, and DUO ECG + Digital Stethoscope.

During an iConsult virtual care session, care teams can quickly and easily collaborate to perform a complete stethoscope examination on a patient. Users wirelessly connect an Eko stethoscope directly with a Caregility APS telehealth device or tablet with just one touch. This streamlined workflow eliminates additional workflow complexities and allows the care team to stay within Caregility’s iConsult application to focus on conducting a high-quality virtual visit.

“Caregility and Eko share a mission to provide healthcare professionals and institutions with technologies that enable them to give their patients the best care possible, in-person or remote,” said Jason Bellet, Co-founder and Chief Strategy Officer at Eko. “By marrying our Eko Connect solution with Caregility’s virtual care platform, we’re redefining the virtual physical exam experience for hundreds of health systems, thousands of clinicians, and millions of patients.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.